Platelets as immune cells in infectious diseases

Future Microbiology

Volumn 8, Issue 11, 2013, Pages 1431-1451

  Speth, Cornelia ^a   Löffler, Jürgen ^b   Krappmann, Sven ^c   Lass Flörl, Cornelia ^a   Rambach, Günter ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

bacteria; fungi; infection; innate immunity; parasites; platelets; thrombocytes; virus

Indexed keywords

AMPHOTERICIN B; ANTIINFECTIVE AGENT; CD40 LIGAND; CD63 ANTIGEN; CHEMOKINE; COMPLEMENT; COMPLEMENT RECEPTOR; CYTOKINE; FLUCONAZOLE; HYDROXYL GROUP; KINOCIDIN; PADGEM PROTEIN; PEROXIDE; POLYPEPTIDE ANTIBIOTIC AGENT; RANTES; SEROTONIN; SUPEROXIDE; THROMBOCIDIN; THROMBOCYTE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

APOPTOSIS; ASPERGILLOSIS; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BLOODSTREAM INFECTION; CANDIDEMIA; CANDIDIASIS; CELL INTERACTION; CELL PHAGOCYTOSIS; CELLULAR IMMUNITY; CHEMOTAXIS; CHRONIC HEPATITIS; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CRYPTOCOCCOSIS; CYTOKINE RELEASE; DENGUE; DRUG RELEASE; ENDOCYTOSIS; FUNGAL ENDOCARDITIS; FUNGAL VIRULENCE; HELMINTHIASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENCE; IMMUNOCOMPETENT CELL; INFLAMMATION; INNATE IMMUNITY; INVASIVE ASPERGILLOSIS; LUNG INFECTION; MALARIA; MYCOSIS; NONHUMAN; OPPORTUNISTIC INFECTION; PARASITOSIS; PATHOGENESIS; PHAGOCYTOSIS; PLATELET MICROPARTICLE; PNEUMOCYSTOSIS; PRIORITY JOURNAL; RESPIRATORY BURST; REVIEW; SCHISTOSOMIASIS; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE LIFESPAN; THROMBOCYTE MEMBRANE; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS; TOXOPLASMOSIS; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS PATHOGENESIS;

ANIMALS; BLOOD PLATELETS; COMMUNICABLE DISEASES; HUMANS; T-LYMPHOCYTES; VIRUSES;

EID: 84888247188     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.13.104     Document Type: Review

References (232)

1. Semple JW, Italiano JE Jr, Freedman J. Platelets and the immune continuum. Nat. Rev. Immunol. 11, 264-274 (2011).
2. Davi G, Patrono C. Platelet activation and atherothrombosis. N. Engl. J. Med. 357, 2482-2494 (2007).
3. Kehrel BE, Jurk K. Platelets at the interface between hemostasis and innate immunity. Trans. Med. Hemother. 31, 379-386 (2004). (Pubitemid 40601899)
4. Michelson AD. Platelets. Michelson AD (Ed.). Academic Press, Elsevier, Amsterdam, The Netherlands (2012).
5. Thon JN, Italiano JE Platelet formation. Semin. Hematol. 47, 220-226 (2010).
6. Italiano JE J.r., Lecine P, Shivdasani R A, Hartwig JH Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes. J. Cell Biol. 147, 1299-1312 (1999). (Pubitemid 30012814)
7. Thon JN, Montalvo A, Patel-Hett S et al. Cytoskeletal mechanics of proplatelet maturation and platelet release. J. Cell Biol. 191, 861-874 (2010).
8. Reed GL, Fitzgerald ML, Polgar J. Molecular mechanisms of platelet exocytosis: insights into the 'secrete' life of thrombocytes. Blood 96, 3334-3342 (2000).
9. von Hundelshausen P., Weber C. Platelets as immune cells: bridging infloammation and cardiovascular disease. Circ. Res. 100, 27-40 (2007). (Pubitemid 46066771)
10. Jenne CN, Urrutia R, Kubes P. Platelets: bridging hemostasis, inflammation, and immunity. Int. J. Lab Hematol. 35, 254-261 (2013).
11. Nurden AT. Platelets, inflammation and tissue regeneration. Thromb. Haemost. 105(Suppl. 1), S13-S33 (2011).
12. Blair P, Flaumenhaft R. Platelet alpha-granules: basic biology and clinical correlates. Blood Rev. 23, 177-189 (2009).
13. Coppinger JA, Cagney G, Toomey S et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 103, 2096-2104 (2004). (Pubitemid 38326225)
14. Zarbock A, Polanowska-Grabowska RK, Ley K. Platelet-neutrophil- interactions: linking hemostasis and inflammation. Blood Rev. 21, 99-111 (2007). (Pubitemid 46428465)
15. Kuwahara M, Sugimoto M, Tsuji S et al. Platelet shape changes and adhesion under high shear flow. Arterioscler. Thromb. Vasc. Biol. 22, 329-334 (2002). (Pubitemid 34127048)
16. Gunay-Aygun M., Huizing M, Gahl WA Molecular defects that affect platelet dense granules. Semin. Thromb. Hemost. 30, 537-547 (2004). (Pubitemid 39426386)
17. Liu Z, Miner JJ, Yago T et al. Differential regulation of human and murine P-selectin expression and function in vivo. J. Exp. Med. 207, 2975-2987 (2010).
18. Weyrich AS, Zimmerman GA. Platelets: signaling cells in the immune continuum. Trends Immunol. 25, 489-495 (2004). (Pubitemid 39490256)
19. Andriantsitohaina R, Gaceb A, Vergori L., Martinez MC Microparticles as regulators of cardiovascular inflammation. Trends Cardiovasc. Med. 22, 88-92 (2012).
20. Jurk K, Kehrel BE Platelets: physiology and biochemistry. Semin. Thromb. Hemost. 31, 381-392 (2005). (Pubitemid 41362342)
21. Nomura S, Fujita S, Nakanishi T et al. Platelet-derived microparticles cause CD154-dependent activation of dendritic cells. Platelets 23, 81-82 (2012).
22. Phillips DR, Law D, Scarborough RM Glycoprotein IIb-IIIa in platelet aggregation: an emerging target for the prevention of acute coronary thrombotic occlusions. Arch. Pathol. Lab. Med. 122, 811-812 (1998).
23. Cox D, Kerrigan SW, Watson SP Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation. J. Thromb. Haemost. 9, 1097-1107 (2011).
24. Brennan M.P., Loughman A, Devocelle M et al. Elucidating the role of Staphylococcus epidermidis serine-aspartate repeat protein G in platelet activation. J. Thromb. Haemost. 7, 1364-1372 (2009).
25. Flaujac C, Boukour S, Cramer-Borde E. Platelets and viruses: an ambivalent relationship. Cell. Mol. Life Sci. 67, 545-556 (2010).
26. Zapotoczna M, Jevnikar Z, Miajlovic H., Kos J, Foster TJ Iron-regulated surface determinant B (IsdB) promotes Staphylococcus aureus adherence to and internalization by non-phagocytic human cells. Cell. Microbiol. 15 (6), 1026-1041 (2012).
27. Ruggeri ZM. The role of von Willebrand factor in thrombus formation. Thromb. Res. 120 (Suppl. 1), S5-S9 (2007). (Pubitemid 46874544)
28. Zahn A, Jennings N, Ouwehand W.H., Allain JP Hepatitis C virus interacts with human platelet glycoprotein VI. J. Gen. Virol. 87, 2243-2251 (2006). (Pubitemid 44178101)
29. Tilley DO, Arman MA, Smolenski A et al. Glycoprotein Ibalpha and FcgammaRIIa play key roles in platelet activation by the colonizing bacterium, Streptococcus oralis. J. Thromb. Haemost. 11(5), 941-950 (2013).
30. O'Neill LA. How Toll-like receptors signal: what we know and what we don't know. Curr. Opin. Immunol. 18, 3-9 (2006). (Pubitemid 43049641)
31. Semple J.W., Freedman J. Platelets and innate immunity. Cell. Mol. Life Sci. 67, 499-511 (2010).
32. Clark SR, Ma AC, Tavener SA et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat. Med. 13, 463-469 (2007). (Pubitemid 46559832)
33. Garraud O, Cognasse F. Platelet Toll-like receptor expression: the link between 'danger' ligands and inflammation. Inflamm. Allergy Drug Targets 9, 322-333 (2010).
34. Thon JN, Peters CG, Machlus KR et al. T-granules in human platelets function in TLR9 organization and signaling. J. Cell Biol. 198, 561-574 (2012).
35. Rambach G, Wurzner R, Speth C. Complement: an efficient sword of innate immunity. Contrib. Microbiol. 15, 78-100 (2008).
36. Del Conde I., Crúz MA, Zhang H., López JA, Afshar-Kharghan V.Platelet activation leads to activation and propagation of the complement system. J. Exp. Med. 201, 871-879 (2005). (Pubitemid 40524457)
37. Peerschke EI, Yin W, Ghebrehiwet B. Complement activation on platelets: implications for vascular inflammation and thrombosis. Mol. Immunol. 47, 2170-2175 (2010).
38. Peerschke EI, Yin W, Ghebrehiwet B. Platelet mediated complement activation. Adv. Exp. Med. Biol. 632, 81-91 (2008).
39. Hamad OA, Back J, Nilsson P.H., Nilsson B., Ekdahl KN Platelets, complement, and contact activation: partners in inflammation and thrombosis. Adv. Exp. Med. Biol. 946, 185-205 (2012).
40. Martel C, Cointe S, Maurice P et al. Requirements for membrane attack complex formation and anaphylatoxins binding to collagen-activated platelets. PLoS ONE 6, e18812 (2011).
41. Peerschke EI, Yin W, Grigg S.E., Ghebrehiwet B. Blood platelets activate the classical pathway of human complement. J. Thromb. Haemost. 4, 2035-2042 (2006). (Pubitemid 44226786)
42. Watanabe H, Kuraya M, Kasukawa R., Yanagisawa H, Yanagisawa M, Fujita T. Analysis of C5a receptor by monoclonal antibody. J. Immunol. Methods 185, 19-29 (1995).
43. Peerschke EI, Ghebrehiwet B. Human blood platelet gC1qR/p33. Immunol. Rev. 180, 56-64 (2001). (Pubitemid 32472852)
44. Nunez D, Charriaut-Marlangue C, Barel M., Benveniste J, Frade R. Activation of human platelets through gp140, the C3d/EBV receptor (CR 2). Eur. J. Immunol. 17, 515-520 (1987). (Pubitemid 17094150)
45. Cosgrove LJ, d'Apice A J, Haddad A, Pedersen J, McKenzie IF. CR3 receptor on platelets and its role in the prostaglandin metabolic pat hway. Immunol. Cell Biol. 65(Pt 6), 453-460 (1987). (Pubitemid 18028336)
46. Vik DP, Fearon DT Cellular distribution of complement receptor type 4 (CR4): expression on human platelets. J. Immunol. 138, 254-258 (1987). (Pubitemid 17218427)
47. Clemetson KJ, Clemetson JM, Proudfoot A.E., Power CA, Baggiolini M, Wells TN Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets. Blood 96, 4046-4054 (2000).
48. Wiesner J, Vilcinskas A. Antimicrobial peptides: the ancient arm of the human immune system. Virulence 1, 440-464 (2010).
49. Yount N.Y., Yeaman MR Peptide antimicrobials: cell wall as a bacterial target. Ann. NY Acad. Sci. 1277, 127-138 (2013).
50. Yeaman MR. Platelets in defense against bacterial pathogens. Cell. Mol. Life Sci. 67, 525-544 (2010).
51. Krijgsveld J, Zaat SA, Meeldijk J et al. Thrombocidins, mirobiocidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines. J. Biol. Chem. 275, 20374-20381 (2000). (Pubitemid 30457613)
52. Love MS, Millholland MG, Mishra S et al. Platelet factor 4 activity against P. falciparum and its translation to nonpeptidic mimics as antimalarials. Cell Host Microbe 12, 815-823 (2012).
53. Kraemer BF, Campbell RA, Schwertz H et al. Novel anti-bacterial activities of beta-defensin 1 in human platelets: suppression of pathogen growth and signaling of neutrophil extracellular trap formation. PLoS Pathog. 7, e1002355 (2011).
54. Arthur JF, Qiao J, Shen Y et al. ITAM receptor-mediated generation of reactive oxygen species in human platelets occurs via Syk-dependent and Syk-independent pathways. J. Thromb. Haemost. 10, 1133-1141 (2012).
55. Blair P, Rex S, Vitseva O et al. Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase. Circ. Res. 104, 346-354 (2009).
56. Lopes-Pires M.E., Casarin AL, Pereira-Cunha FG, Lorand-Metze I, Antunes E., Marcondes S. Lipopolysaccharide treatment reduces rat platelet aggregation independent of intracellular reactive-oxygen species generation. Platelets 23, 195-201 (2012).
57. Martin-Ventura J.L., Madrigal-Matute J, Martinez-Pinna R et al. Erythrocytes, leukocytes and platelets as a source of oxidative stress in chronic vascular diseases: detoxifying mechanisms and potential therapeutic options. Thromb. Haemost. 108, 435-442 (2012).
58. Zander D, Klinger MH The blood platelets contribution to innate host defense - what they have learned from their big brothers. Biotechnol. J. 4, 914-926 (2009).
59. White JG, Clawson CC Effects of large latex particle uptake of the surface connected canalicular system of blood platelets: a freeze-fracture and cytochemical study. Ultrastruct. Pathol. 2, 277-287 (1981). (Pubitemid 12195168)
60. White JG, Clawson CC Effects of small latex particle uptake on the surface connected canalicular system of blood platelets: a freeze-fracture and cytochemical study. Diagn. Histopathol. 5, 3-10 (1982). (Pubitemid 12182265)
61. Worth RG, Chien CD, Chien P, Reilly M P, McKenzie SE, Schreiber AD Platelet FcgammaRIIA binds and internalizes IgG-containing complexes. Exp. Hematol. 34, 1490-1495 (2006). (Pubitemid 44548115)
62. Youssefian T, Drouin A, Masse J.M., Guichard J., Cramer EM Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation. Blood 99, 4021-4029 (2002). (Pubitemid 35332043)
63. Zucker-Franklin D., Seremetis S, Zheng ZY Internalization of human immunodeficiency virus type I and other retroviruses by megakaryocytes and platelets. Blood 75, 1920-1923 (1990). (Pubitemid 20180278)
64. Huang ZY, Chien P, Indik Z.K., Schreiber AD Human platelet FcgammaRIIA and phagocytes in immune-complex clearance. Mol. Immunol. 48, 691-696 (2011).
65. Seizer P, Gawaz M, May A E. Platelet-monocyte interactions - a dangerous liaison linking thrombosis, inflammation and atherosclerosis. Curr. Med. Chem. 15, 1976-1980 (2008).
66. Gleissner CA, von HP, Ley K. Platelet chemokines in vascular disease. Arterioscler. Thromb. Vasc. Biol. 28, 1920-1927 (2008).
67. Li Z, Yang F, Dunn S., Gross AK, Smyth SS Platelets as immune mediators: their role in host defense responses and sepsis. Thromb. Res. 127, 184-188 (2011).
68. Lievens D, von HP Platelets in atherosclerosis. Thromb. Haemost. 106, 827-838 (2011).
69. Henn V, Slupsky JR, Grafe M et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391, 591-594 (1998). (Pubitemid 28157601)
70. Lam FW, Burns AR, Smith C.W., Rumbaut RE Platelets enhance neutrophil transendothelial migration via P-selectin glycoprotein ligand-1. Am. J. Physiol. Heart Circ. Physiol. 300, H468-H475 (2011).
71. Maugeri N, Rovere-Querini P, Evangelista V et al. Neutrophils phagocytose activated platelets in vivo: a phosphatidylserine, P-selectin, and {beta}2 integrin-dependent cell clearance program. Blood 113, 5254-5265 (2009).
72. Santoso S, Sachs UJ, Kroll H et al. The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1. J. Exp. Med. 196, 679-691 (2002). (Pubitemid 35024445)
73. Knijff-Dutmer E.A., Koerts J, Nieuwland R., Kalsbeek-Batenburg EM, van de Laar MA. Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. Arthritis Rheum. 46, 1498-1503 (2002). (Pubitemid 34620195)
74. Mause SF, von Hundelshausen P, Zernecke A, Koenen R.R., Weber C. Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler. Thromb. Vasc. Biol. 25, 1512-1518 (2005). (Pubitemid 40923377)
75. Sprague DL, Elzey BD, Crist S.A., Waldschmidt TJ, Jensen RJ, Ratliff TL. Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles. Blood 111, 5028-5036 (2008).
76. Hager M, Cowland JB, Borregaard N. Neutrophil granules in health and disease. J. Intern. Med. 268, 25-34 (2010).
77. Wright HL, Moots RJ, Bucknall R.C., Edwards SW Neutrophil function in inflammation and inflammatory diseases. Rheumatology (Oxford) 49, 1618-1631 (2010).
78. Assinger A, Laky M, Schabbauer G et al. Efficient phagocytosis of periodontopathogens by neutrophils requires plasma factors, platelets and TLR2. J. Thromb. Haemost. 9, 799-809 (2011).
79. Miedzobrodzki J, Panz T, Plonka PM et al. Platelets augment respiratory burst in neutrophils activated by selected species of Gram-positive or Gram-negative bacteria. Folia Histochem. Cytobiol. 46, 383-388 (2008).
80. Kasper B, Brandt E, Brandau S., Petersen F. Platelet factor 4 (CXC chemokine ligand 4) differentially regulates respiratory burst, survival, and cytokine expression of human monocytes by using distinct signaling pathways. J. Immunol. 179, 2584-2591 (2007).
81. Scheuerer B, Ernst M, Durrbaum-Landmann I et al. The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages. Blood 95, 1158-1166 (2000). (Pubitemid 30099821)
82. von Hundelshausen P., Koenen RR, Sack M et al. Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood 105, 924-930 (2005). (Pubitemid 40170856)
83. von Hundelshausen P., Koenen RR, Weber C. Platelet-mediated enhancement of leukocyte adhesion. Microcirculation 16, 84-96 (2009).
84. Scull CM, Hays WD, Fischer TH Macrophage pro-inflammatory cytokine secretion is enhanced following interaction with autologous platelets. J. Inflamm. (Lond.) 7, 53 (2010).
85. Czapiga M, Kirk AD, Lekstrom-Himes J. Platelets deliver costimulatory signals to antigen-presenting cells: a potential bridge between injury and immune activation. Exp. Hematol. 32, 135-139 (2004). (Pubitemid 38177638)
86. Hagihara M, Higuchi A, Tamura N et al. Platelets, after exposure to a high shear stress, induce IL-10-producing, mature dendritic cells in vitro. J. Immunol. 172, 5297-5303 (2004). (Pubitemid 38542027)
87. Martinson J, Bae J, Klingemann H.G., Tam Y. Activated platelets rapidly up-regulate CD40L expression and can effectively mature and activate autologous ex vivo differentiated DC. Cytotherapy 6, 487-497 (2004). (Pubitemid 39433583)
88. Elzey BD, Tian J, Jensen RJ et al. Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. Immunity 19, 9-19 (2003). (Pubitemid 36859897)
89. Solanilla A, Pasquet JM, Viallard JF et al. Platelet-associated CD154 in immune thrombocytopenic purpura. Blood 105, 215-218 (2005). (Pubitemid 40053085)
90. Wa ng J., Zhang W, Nardi M.A., Li Z. HIV-1 Tat-induced platelet activation and release of CD154 contribute to HIV-1-associated autoimmune thrombocytopenia. J. Thromb. Haemost. 9, 562-573 (2011).
91. Chapman LM, Aggrey AA, Field DJ et al. Platelets present antigen in the context of MHC class I. J. Immunol. 189, 916-923 (2012).
92. + T cells for enhanced germinal center formation. J. Leukoc. Biol. 78, 80-84 (2005). (Pubitemid 40979946)
93. +) T-cell differentiation via multiple chemokines in humans. Thromb. Haemost. 106, 353-362 (2011).
94. Al MM, Darouiche RO Sepsis syndrome, bloodstream infections, and device-related infections. Med. Clin. North Am. 96, 1203-1223 (2012).
95. Vincent JL, Sakr Y, Sprung CL et al. Sepsis in European intensive care units: results of the SOAP study. Crit. Care Med. 34, 344-353 (2006). (Pubitemid 43145611)
96. Martin GS. Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert Rev. Anti Infect. Ther. 10, 701-706 (2012).
97. Gafter-Gvili A., Mansur N, Bivas A et al. Thrombocytopenia in Staphylococcus aureus bacteremia: risk factors and prognostic importance. Mayo Clin. Proc. 86, 389-396 (2011).
98. Mavrommatis AC, Theodoridis T, Orfanidou A., Roussos C, Christopoulou-Kokkinou V, Zakynthinos S. Coagulation system and platelets are fully activated in uncomplicated sepsis. Crit. Care Med. 28, 451-457 (2000). (Pubitemid 30120888)
99. Vandijck DM, Blot SI, De Waele JJ, Hoste EA, Vandewoude KH, Decruyenaere JM Thrombocytopenia and outcome in critically ill patients with bloodstream infection. Heart Lung 39, 21-26 (2010).
100. Bozza FA, Shah AM, Weyrich AS, Zimmerman GA. Amicus or adversary: platelets in lung biology, acute injury, and inflammation. Am. J. Respir. Cell Mol. Biol. 40, 123-134 (2009).
101. Manfredi AA, Rovere-Querini P, Maugeri N. Dangerous connections: neutrophils and the phagocytic clearance of activated platelets. Curr. Opin. Hematol. 17, 3-8 (2010).
102. Aslam R, Speck ER, Kim M et al. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood 107, 637-641 (2006). (Pubitemid 43076388)
103. Lourbakos A, Yuan YP, Jenk ins A L et al. Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity. Blood 97, 3790-3797 (2001).
104. Orth D, Wurzner R. Complement in typical hemolytic uremic syndrome. Semin. Thromb. Hemost. 36, 620-624 (2010).
105. Guo YL, Liu DQ, Bian Z, Zhang C.Y., Zen K. Down-regulation of platelet surface CD47 expression in Escherichia coli O 157: H 7 infection-induced thrombocytopenia. PLoS ONE 4, e7131 (2009).
106. Kraemer BF, Campbell RA, Schwertz H et al. Bacteria differentially induce degradation of Bcl-xL, a survival protein, by human platelets. Blood 120, 5014-5020 (2012).
107. Towhid ST, Nega M, Schmidt EM et al. Stimulation of platelet apoptosis by peptidoglycan from Staphylococcus aureus 113. Apoptosis 17, 998-1008 (2012).
108. Bhakdi S, Tranum-Jensen J. Alpha-toxin of Staphylococcus aureus. Microbiol. Rev. 55, 733-751 (1991). (Pubitemid 21895174)
109. Bayer AS, Ramos MD, Menzies B.E., Yea man MR, Shen AJ, Cheung AL Hyperproduction of alpha-toxin by Staphylococcus aureus results in paradoxically reduced virulence in experimental endocarditis: a host defense role for platelet microbicidal proteins. Infect. Immun. 65, 4652-4660 (1997). (Pubitemid 27463238)
110. Bryant AE, Bayer CR, Chen R.Y., Guth PH, Wallace RJ, Stevens DL Vascular dysfunction and ischemic destruction of tissue in Streptococcus pyogenes infection: the role of streptolysin O-induced platelet/neutrophil complexes. J. Infect. Dis. 192, 1014-1022 (2005). (Pubitemid 41266798)
111. Johnson MK, Boese-Marrazzo D, Pierce W.A., Jr. Effects of pneumolysin on human polymorphonuclear leukocytes and platelets. Infect. Immun. 34, 171-176 (1981). (Pubitemid 11004962)
112. Dall L, Miller T, Herndon B., Diez I, Dew M. Platelet depletion and severity of streptococcal endocarditis. Can. J. Infect. Dis. 9, 359-366 (1998). (Pubitemid 29048931)
113. Dhawan VK, Bayer AS, Yeaman MR in vitro resistance to thrombin-induced platelet microbicidal protein is associated with enhanced progression and hematogenous dissemination in experimental Staphylococcus aureus infective endocarditis. Infect. Immun. 66, 3476-3479 (1998). (Pubitemid 28303159)
114. Kwakman PH, Krijgsveld J, de Boer L et al. Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements. J. Biol. Chem. 286, 43506-43514 (2011).
115. Dankert J, Krijgsveld J, van Der Werff J, Joldersma W, Zaat SA. Platelet microbicidal activity is an important defense factor against viridans streptococcal endocarditis. J. Infect. Dis. 184, 597-605 (2001). (Pubitemid 32783551)
116. Dankert J, van der Werff J, Zaat SA, Joldersma W, Klein D, Hess J. Involvement of bactericidal factors from thrombin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditis. Infect. Immun. 63, 663-671 (1995).
117. Peschel A, Collins LV Staphylococcal resistance to antimicrobial peptides of mammalian and bacterial origin. Peptides 22, 1651-1659 (2001). (Pubitemid 32918244)
118. Peschel A. How do bacteria resist human antimicrobial peptides? Trends Microbiol. 10, 179-186 (2002). (Pubitemid 34242955)
119. Kupferwasser LI, Skurray RA, Brown M.H., Firth N., Yeaman MR, Bayer AS Plasmid-mediated resistance to thrombin-induced platelet microbicidal protein in staphylococci: role of the qacA locus. Antimicrob. Agents Chemother. 43, 2395-2399 (1999). (Pubitemid 29471216)
120. Gritsenko VA, Ivanov I, Zhurlov OS [Physico-chemical properties of staphylococci of different species in resistance to human thrombodefensins]. Zh. Mikrobiol. Epidemiol. Immunobiol. 4, 16-19 (2006).
121. Yang SJ, Bayer AS, Mishra NN et al. The Staphylococcus aureus two-component regulatory system, GraRS, senses and confers resistance to selected cationic antimicrobial peptides. Infect. Immun. 80, 74-81 (2012).
122. Semeraro N, Ammollo CT, Semeraro F, Colucci M. Sepsis, thrombosis and organ dysfunction. Thromb. Res. 129, 290-295 (2012).
123. Esmon CT. Molecular circuits in thrombosis and inflammation. Thromb. Haemost. 109, 416-420 (2013).
124. Jung CJ, Yeh C Y, Shun CT et al. Platelets enhance biofilm formation and resistance of endocarditis-inducing streptococci on the injured heart valve. J. Infect. Dis. 205, 1066-1075 (2012).
125. Hottz ED, Oliveira MF, Nunes PC et al. Dengue induces platelet activation mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspases. J. Thromb. Haemost. 11(5), 951-962 (2013).
126. Passos AM, Treitinger A, Spada C. An overview of the mechanisms of HIV-related thrombocytopenia. Acta Haematol. 124, 13-18 (2010).
127. de Almeida A.J., Campos-de-Magalhaes M, Antonietti CL et al. Autoimmune thrombocytopenia related to chronic hepatitis C virus infection. Hematology 14, 49-58 (2009).
128. Nagamine T, Ohtuka T, Takehara K., Arai T, Takagi H, Mori M. Thrombocytopenia associated with hepatitis C viral infection. J. Hepatol. 24, 135-140 (1996). (Pubitemid 26059114)
129. Hamaia S, Li C, Allain JP The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines. Blood 98, 2293-2300 (2001).
130. Chaipan C, Soilleux EJ, Simpson P et al. DC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by platelets. J. Virol. 80, 8951-8960 (2006). (Pubitemid 44359969)
131. Boukour S, Masse JM, Benit L, Dubart-Kupperschmitt A, Cramer EM Lentivirus degradation and DC-SIGN expression by human platelets and megakaryocytes. J. Thromb. Haemost. 4, 426-435 (2006).
132. Thota S, Kistangari G, Daw H., Spiro T. Immune thrombocytopenia in adults: an update. Cleve. Clin. J. Med. 79, 641-650 (2012).
133. Dimitroulis D, Valsami S, Stamopoulos P., Kouraklis G. Immunological HCV-associated thrombocytopenia: short review. Clin. Dev. Immunol. 378653 (2012).
134. Zhang W, Nardi MA, Borkowsky W, Li Z., Karpatkin S. Role of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis C-related immunologic thrombocytopenia. Blood 113, 4086-4093 (2009).
135. Lin YS, Yeh T M, Lin CF et al. Molecular mimicry between virus and host and its implications for dengue disease pathogenesis. Exp. Biol. Med. (Maywood) 236, 515-523 (2011).
136. Wan SW, Lin CF, Yeh TM et al. Autoimmunity in dengue pathogenesis. J. Formos. Med. Assoc. 112, 3-11 (2013).
137. Aster RH. Pooling of platelets in the spleen: role in the pathogenesis of 'hypersplenic' thrombocytopenia. J. Clin. Invest. 45, 645-657 (1966).
138. Adinolfi LE, Giordano MG, Andreana A et al. Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis. Br. J. Haematol. 113, 590-595 (2001). (Pubitemid 32524375)
139. Sanjo A, Satoi J, Ohnishi A., Maruno J, Fukata M, Suzuki N. Role of elevated platelet-associated immunoglobulin G and hypersplenism in thrombocytopenia of chronic liver diseases. J. Gastroenterol. Hepatol. 18, 638-644 (2003). (Pubitemid 36791700)
140. Weksler BB. Review article: the pathophysiology of thrombocytopenia in hepatitis C virus infection and chronic liver disease. Aliment. Pharmacol. Ther. 26(Suppl. 1), 13-19 (2007). (Pubitemid 47631869)
141. Kaushansky K. Thrombopoietin. N. Engl. J. Med. 339, 746-754 (1998). (Pubitemid 28417359)
142. Aref S, Mabed M, Selim T., Goda T, Khafagy N. Thrombopoietin (TPO) levels in hepatic patients with thrombocytopenia. Hematology 9, 351-356 (2004). (Pubitemid 40123583)
143. Giannini E, Borro P, Botta F et al. Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis. J. Hepatol. 37, 572-577 (2002). (Pubitemid 35305535)
144. Kowalska MA, Ratajczak J, Hoxie J et al. Megakaryocyte precursors, megakaryocytes and platelets express the HIV co-receptor CXCR4 on their surface: determination of response to stromal-derived factor-1 by megakaryocytes and platelets. Br. J. Haematol. 104, 220-229 (1999). (Pubitemid 29083327)
145. Sato T, Sekine H, Kakuda H., Miura N, Sunohara M, Fuse A. HIV infection of megakaryocytic cell lines. Leuk. Lymphoma 36, 397-404 (2000). (Pubitemid 30060191)
146. Cines DB, Liebman H, Stasi R. Pathobiology of secondary immune thrombocytopenia. Semin. Hematol. 46, S2-S14 (2009).
147. Bordin G, Ballare M, Zigrossi P et al. A laboratory and thrombokinetic study of HCV-associated thrombocytopenia: a direct role of HCV in bone marrow exhaustion? Clin. Exp. Rheumatol. 13(Suppl. 13), S39-S43 (1995).
148. de Almeida A.J., Campos-de-Magalhaes M, de Melo Marcal OP et al. Hepatitis C virus-associated thrombocytopenia: a controlled prospective, virological study. Ann. Hematol. 83, 434-440 (2004).
149. Iga D, Tomimatsu M, Endo H., Ohkawa S, Yamada O. Improvement of thrombocytopenia with disappearance of HCV RNA in patients treated by interferonalpha therapy: possible etiology of HCV-associated immune thrombocytopenia. Eur. J. Haematol. 75, 417-423 (2005). (Pubitemid 41445082)
150. Crapnell K, Zanjani ED, Chaudhuri A, Ascensao J.L., St Jeor S, Maciejewski JP in vitro infection of megakaryocytes and their precursors by human cytomegalovirus. Blood 95, 487-493 (2000). (Pubitemid 30041660)
151. Maurice A, Marchand-Arvier M, Edert D., Le Faou A, Gondrexon G, Vigneron C. The virucidal effect of platelet concentrates: preliminary study and first conclusions. Platelets 13, 219-222 (2002). (Pubitemid 34787732)
152. Mohan KV, Rao SS, Atreya CD Antiviral activity of selected antimicrobial peptides against vaccinia virus. Antiviral Res. 86, 306-311 (2010).
153. Auerbach DJ, Lin Y, Miao H et al. Identification of the platelet-derived chemokine CXCL4/PF-4 as a broad-spectrum HIV-1 inhibitor. Proc. Natl Acad. Sci. USA 109, 9569-9574 (2012).
154. Klinger MH, Wilhelm D, Bubel S., Sticherling M, Schroder JM, Kuhnel W. Immunocytochemical localization of the chemokines RANTES and MIP-1 alpha within human platelets and their release during storage. Int. Arch. Allergy Immunol. 107, 541-546 (1995).
155. + T cells. Science 270, 1811-1815 (1995).
156. Nouer SA, Nucci M, Kumar N.S., Grazziutti M., Restrepo A, Anaissie E. Baseline platelet count and creatinine clearance rate predict the outcome of neutropenia-related invasive aspergillosis. Clin. Infect. Dis. 54, e173-e183 (2012).
157. Chang FY, Singh N, Gayowski T et al. Thrombocytopenia in liver transplant recipients: predictors, impact on fungal infections, and role of endogenous thrombopoietin. Transplantation 69, 70-75 (2000). (Pubitemid 30062611)
158. Woth G, Tokes-Fuzesi M, Magyarlaki T., Kovacs GL, Vermes I, Muhl D. Activated platelet-derived microparticle numbers are elevated in patients with severe fungal (Candida albicans) sepsis. Ann. Clin. Biochem. 49, 554-560 (2012).
159. Maisch PA, Calderone RA Adherence of Candida albicans to a fibrin-platelet matrix formed in vitro. Infect. Immun. 27, 650-656 (1980). (Pubitemid 10144964)
160. Maisch PA, Calderone RA Role of surface mannan in the adherence of Candida albicans to fibrin-platelet clots formed in vitro. Infect. Immun. 32, 92-97 (1981). (Pubitemid 11156908)
161. Rotrosen D, Calderone RA, Edwards JE Jr. Adherence of Candida species to host tissues and plastic surfaces. Rev. Infect. Dis. 8, 73-85 (1986).
162. Klotz SA, Harrison JL, Misra R P. Aggregated platelets enhance adherence of Candida yeasts to endothelium. J. Infect. Dis. 160, 669-677 (1989). (Pubitemid 19247651)
163. Robert R, Nail S, Marot-Leblond A et al. Adherence of platelets to Candida species in vivo. Infect. Immun. 68, 570-576 (2000). (Pubitemid 30056509)
164. Robert R, Mahaza C, Miegeville M., Ponton J, Marot-Leblond A, Senet JM Binding of resting platelets to Candida albicans germ tubes. Infect. Immun. 64, 3752-3757 (1996). (Pubitemid 26298701)
165. Willcox M, Webb B, Thakur A., Harty D. Interactions between Candida species and platelets. J. Med. Microbiol. 47, 103-110 (1998). (Pubitemid 28041252)
166. Bertling A, Niemann S, Uekotter A et al. Candida albicans and its metabolite gliotoxin inhibit platelet function via interaction with thiols. Thromb. Haemost. 104(2), 270-278 (2010).
167. Carvalho Neiva T.J., dos Santos JI. Effect of pathogenic yeasts on human platelet aggregation. Braz. J. Infect. Dis. 7, 370-374 (2003).
168. Rodland EK, Ueland T, Pedersen TM et al. Activation of platelets by Aspergillus fumigatus and potential role of platelets in the immunopathogenesis of aspergillosis. Infect. Immun. 78, 1269-1275 (2010).
169. Perkhofer S, Kainzner B, Kehrel B.E., Dierich M P, Nussbaumer W, Lass-Florl C. Potential antifungal effects of human platelets against zygomycetes in vitro. J. Infect. Dis. 200, 1176-1179 (2009).
170. Kurihara K, Shingo Y, Miura NN et al. Effect of CAWS, a
171. Skerl KG, Calderone RA, Sreevalsan T. Platelet interactions with Candida albicans. Infect. Immun. 34, 938-943 (1981). (Pubitemid 12247196)
172. Sheth NK, Kurup V P, Barron BA The role of Aspergillus fumigatus antigens in blood coagulation and platelet function. Microbios 28, 91-96 (1980). (Pubitemid 11182672)
173. Speth C, Hagleitner M, Ott H.W., Wurzner R., Lass-Florl C, Rambach G. Aspergillus fumigatus activates thrombocytes by secretion of soluble compounds. J. Infect. Dis. 207, 823-833 (2013).
174. Christin L, Wysong DR, Meshulam T, Hastey R., Simons ER, Diamond RD Human platelets damage Aspergillus fumigatus hyphae and may supplement killing by neutrophils. Infect. Immun. 66, 1181-1189 (1998). (Pubitemid 28101163)
175. Perkhofer S, Kehrel BE, Dierich MP et al. Human platelets attenuate Aspergillus species via granule-dependent mechanisms. J. Infect. Dis. 198, 1243-1246 (2008).
176. Perkhofer S, Striessnig B, Sartori B., Hausott B, Ott HW, Lass-Florl C. Interaction of platelets and anidulafungin against Aspergillus fumigatus. Antimicrob. Agents Chemother. 57, 626-628 (2013).
177. Drago L, Bortolin M, Vassena C., Taschieri S, Del FM. Antimicrobial activity of pure platelet-rich plasma against microorganisms isolated from oral cavity. BMC Microbiol. 13, 47 (2013).
178. Tang Y, Yeaman M, Selsted ME Antimicrobial peptides from human platelets. Infect. Immun. 70, 6524-6533 (2002). (Pubitemid 35387877)
179. Yeaman MR, Ibrahim AS, Edwards JE Jr, Bayer AS, Ghannoum MA Thrombin-induced rabbit platelet microbicidal protein is fungicidal in vitro. Antimicrob. Agents Chemother. 37, 546-553 (1993). (Pubitemid 23072601)
180. Yeaman MR, Soldan SS, Ghannoum M.A., Edwards JE Jr, Filler SG, Bayer AS Resistance to platelet microbicidal protein results in increased severity of experimental Candida albicans endocarditis. Infect. Immun. 64, 1379-1384 (1996). (Pubitemid 26102404)
181. Perkhofer S, Niederegger H, Blum G et al. Interaction of 5-hydroxytryptamine (serotonin) against Aspergillus spp. in vitro. Int. J. Antimicrob. Agents 29, 424-429 (2007). (Pubitemid 46349592)
182. Yeaman M, Sullam P, Dazin P., Ghannoum M, Edwards J, Bayer A. Fluconazole and platelet microbicidal protein inhibit Candida adherence to platelets in vitro. Antimicrob. Agents Chemother. 38, 1460-1465 (1994). (Pubitemid 24203552)
183. Yeaman MR, Cheng D, Desai B et al. Susceptibility to thrombin-induced platelet microbicidal protein is associated with increased fluconazole efficacy against experimental endocarditis due to Candida albicans. Antimicrob. Agents Chemother. 48, 3051-3056 (2004). (Pubitemid 38989174)
184. Perkhofer S, Trappl K, Nussbaumer W., Dierich M, Lass-Flörl C. Potential synergistic activity of antimycotic substances in combination with human platelets against Aspergillus fumigatus. J. Antimicrob. Chemother. 8, 1309-1311 (2010).
185. Perkhofer S, Trappl K, Striessnig B., Nussbaumer W, Lass-Florl C. Platelets enhance activity of antimycotic substances against non-Aspergillus fumigatus Aspergillus species in vitro. Med. Mycol. 49, 157-166 (2011).
186. Heller I, Leitner S, Dierich M.P., Lass-Florl C.Serotonin (5-HT) enhances the activity of amphotericin B against Aspergillus fumigatus in vitro. Int. J. Antimicrob. Agents 24, 401-404 (2004). (Pubitemid 39369488)
187. Haselmayer P, Grosse-Hovest L, von Landenberg P, Schild H, Radsak MP TREM-1 ligand expression on platelets enhances neutrophil activation. Blood 110, 1029-1035 (2007). (Pubitemid 47267444)
188. Bruns S, Kniemeyer O, Hasenberg M et al. Production of extracellular traps against Aspergillus fumigatus in vitro and in infected lung tissue is dependent on invading neutrophils and influenced by hydrophobin RodA. PLoS Pathog. 6, e1000873 (2010).
189. McCormick A, Heesemann L, Wagener J et al. NETs formed by human neutrophils inhibit growth of the pathogenic mold Aspergillus fumigatus. Microbes Infect. 12, 928-936 (2010).
190. Mircescu MM, Lipuma L, van Roojien N, Pamer EG, Hohl TM Essential role for neutrophils but not alveolar macrophages at early time points following Aspergillus fumigatus infection. J. Infect. Dis. 200, 647-656 (2009).
191. Urban CF, Reichard U, Brinkmann V., Zychlinsky A. Neutrophil extracellular traps capture and kill Candida albicans yeast and hyphal forms. Cell. Microbiol. 8, 668-676 (2006). (Pubitemid 43372744)
192. da Rocha Pitta MG, da Rocha Pitta MG, de Melo Rêgo MJ, Galdino SL. The evolution of drugs on schistosoma treatment: looking to the past to improve the future. Mini Rev. Med. Chem. 13, 493-508 (2013).
193. Stanley RG, Ngaiza JR, Wambayi E, Lewis J., Doenhoff MJ Platelets as an innate defence mechanism against Schistosoma mansoni infections in mice. Parasite Immunol. 25, 467-473 (2003). (Pubitemid 38333808)
194. Joseph M, Auriault C, Capron A., Vorng H, Viens P. A new function for platelets: IgE-dependent killing of schistosomes. Nature 303, 810-812 (1983). (Pubitemid 13054494)
195. Damonneville M, Pancre V, Capron A., Auriault C. Protection of rats against Schistosoma mansoni infection induced by platelets stimulated with the murine recombinant tumor necrosis factor alpha. Int. Arch. Allergy Appl. Immunol. 92, 361-363 (1990).
196. DeMarco R, Kowaltowski AT, Mortara R.A., Verjovski-Almeida S.Molecular characterization and immunolocalization of Schistosoma mansoni ATP-diphosphohydrolase. Biochem. Biophys. Res. Commun. 307, 831-838 (2003). (Pubitemid 36871648)
197. Martins SM, Torres CR, Ferreira ST Inhibition of the ecto-ATP diphosphohydrolase of Schistosoma mansoni by thapsigargin. Biosci. Rep. 20, 369-381 (2000). (Pubitemid 32280914)
198. Matowicka-Karna J., Kemona H. [Evaluation of functional state of blood platelets in patients infected with Echinococcus granulosus]. Wiad. Parazytol. 47, 651-654 (2001).
199. Matowicka-Karna J., Kemona H, Dymicka-Piekarska V, Butkiewicz A. [The secretory activity of blood platelets - beta-thromboglobulin and platelet factor 4 in echinococcosis]. Pol. Merkur. Lekarski 19, 172-174 (2005). (Pubitemid 41242205)
200. Matowicka-Karna J., Kemona H, Dymicka-Piekarska V, Butkiewicz A. Activation of blood platelets in echinococcosis - CD62P and CD63 expression. Parasitol. Res. 98, 214-217 (2006). (Pubitemid 43207311)
201. Polack B, Peyron F, Auriault C. Platelet cytotoxicity against parasites. Nouv. Rev. Fr. Hematol. 33, 317-322 (1991).
202. Kakuda T, Ooi HK, Oku Y, Kamiya M. Participation of platelets in protection against larval Taenia taeniaeformis infection in mice. Int. Arch. Allergy Immunol. 109, 295-297 (1996). (Pubitemid 26056208)
203. Kaye A. Toxoplasmosis: diagnosis, treatment, and prevention in congenitally exposed infants. J. Pediatr. Health Care 25, 355-364 (2011).
204. Chu mpita zi BF, Simon J, Polack B et al. Human platelet inhibition of Toxoplasma gondii growth. Clin. Exp. Immunol. 111, 325-333 (1998). (Pubitemid 28088313)
205. Henderson WR, Chi EY Cytotoxic activity of 13-hydroxyoctadecadienoic acid against Toxoplasma gondii. Parasitology 105(Pt 3), 343-347 (1992).
206. Yong EC, Chi EY, Fritsche T.R., Henderson WR Jr. Human platelet-mediated cytotoxicity against Toxoplasma gondii: role of thromboxane. J. Exp. Med. 173, 65-78 (1991).
207. Cserti-Gazdewich C.M., Mayr WR, Dzik WH Plasmodium falciparum malaria and the immunogenetics of ABO, HLA, and CD36 (platelet glycoprotein IV). Vox Sang. 100, 99-111 (2011).
208. Cox D, McConkey S. The role of platelets in the pathogenesis of cerebral malaria. Cell. Mol. Life Sci. 67, 557-568 (2010).
209. Facer CA, Theodoridou A. Elevated plasma levels of P-selectin (GMP-140/CD62P) in patients with Plasmodium falciparum malaria. Microbiol. Immunol. 38, 727-731 (1994). (Pubitemid 24303874)
210. Osim EE, Adegunloye BJ, Emeribe AO in vivo platelet aggregation in acute malaria. Acta Trop. 49, 227-232 (1991).
211. Emuchay CI, Usanga EA Increased platelet factor 3 activity in Plasmodium falciparum malaria. East Afr. Med. J. 74, 527-529 (1997). (Pubitemid 127387173)
212. Patel U, Gandhi G, Friedman S., Niranjan S. Thrombocytopenia in malaria. J. Natl Med. Assoc. 96, 1212-1214 (2004). (Pubitemid 39215617)
213. Erhart LM, Yingyuen K, Chuanak N et al. Hematologic and clinical indices of malaria in a semi-immune population of western Thailand. Am. J. Trop. Med. Hyg. 70, 8-14 (2004). (Pubitemid 39220509)
214. McMorran BJ, Marshall VM, de Graaf C et al. Platelets kill intraerythrocytic malarial parasites and mediate survival to infection. Science 323, 797-800 (2009).
215. Gerardin P, Rogier C, Ka A.S., Jouvencel P., Brousse V, Imbert P. Prognostic value of thrombocytopenia in African children with falciparum malaria. Am. J. Trop. Med. Hyg. 66, 686-691 (2002). (Pubitemid 35001039)
216. Ladhani S, Lowe B, Cole A.O., Kowuondo K., Newton CR Changes in white blood cells and platelets in children with falciparum malaria: relationship to disease outcome. Br. J. Haematol. 119, 839-847 (2002). (Pubitemid 35366233)
217. McMorran BJ, Wieczorski L, Drysdale KE et al. Platelet factor 4 and Duffy antigen required for platelet killing of Plasmodium falciparum. Science 338, 1348-1351 (2012).
218. Grau GE, Mackenzie CD, Carr RA et al. Platelet accumulation in brain microvessels in fatal pediatric cerebral malaria. J. Infect. Dis. 187, 461-466 (2003). (Pubitemid 36184587)
219. Wassmer SC, Combes V, Candal F.J., Juhan-Vague I, Grau GE Platelets potentiate brain endothelial alterations induced by Plasmodium falciparum. Infect. Immun. 74, 645-653 (2006). (Pubitemid 43023120)
220. Wassmer SC, Taylor T, Maclennan CA et al. Platelet-induced clumping of Plasmodium falciparum-infected erythrocytes from Malawian patients with cerebral malaria-possible modulation in vivo by thrombocytopenia. J. Infect. Dis. 197, 72-78 (2008). (Pubitemid 351263469)
221. Levi M, van der Poll T, ten Cate H. Tissue factor in infection and severe inflammation. Semin. Thromb. Hemost. 32, 33-39 (2006).
222. Czapiga M, Gao JL, Kirk A, Lekstrom-Himes J. Human platelets exhibit chemotaxis using functional N-formyl peptide receptors. Exp. Hematol. 33, 73-84 (2005). (Pubitemid 40127646)
223. Othman M, Labelle A, Mazzetti I., Elbatarny HS, Lillicrap D. Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance. Blood 109, 2832-2839 (2007). (Pubitemid 46482078)
224. Antczak AJ, Vieth JA, Singh N, Worth RG Internalization of IgG-coated targets results in activation and secretion of soluble CD40 ligand and RANTES by human platelets. Clin. Vaccine Immunol. 18, 210-216 (2011).
225. Alonzo MT, Lacuesta TL, Dimaano EM et al. Platelet apoptosis and apoptotic platelet clearance by macrophages in secondary dengue virus infections. J. Infect. Dis. 205, 1321-1329 (2012).
226. Liebman H. Other immune thrombocytopenias. Semin. Hematol. 44, S24-S34 (2007). (Pubitemid 350256800)
227. Kulkosky J, Laptev A, Shetty S et al. Human immunodeficiency virus type 1 Vpr alters bone marrow cell function. Blood 93, 1906-1915 (1999). (Pubitemid 29128492)
228. Pan R, Wang J, Nardi M.A., Li Z. The inhibition effect of anti-GPIIIa49-66 antibody on megakaryocyte differentiation. Thromb. Haemost. 106, 484-490 (2011).
229. Moses A, Nelson J, Bagby GC Jr. The influence of human immunodeficiency virus-1 on hematopoiesis. Blood 91, 1479-1495 (1998). (Pubitemid 28110310)
230. Isomura H, Yoshida M, Namba H et al. Suppressive effects of human herpesvirus-6 on thrombopoietin-inducible megakaryocytic colony formation in vitro. J. Gen. Virol. 81, 663-673 (2000). (Pubitemid 30105496)
231. Peck-Radosavljevic M. Thrombocytopenia in liver disease. Can. J. Gastroenterol. 14(Suppl. D), D60-D66 (2000).
232. Carvalho Neiva T.J., dos Santos JI. Effect of pathogenic yeasts on human platelet aggregation. Braz. J. Infect. Dis. 7, 370-374 (2003).